Table 1.
Baseline characteristics of participants
| Characteristics | Control (n = 70) |
Intervention (n = 78) |
P value |
|---|---|---|---|
| Age, mean (95% CI), y | 81.6 (79.5 to 83.6) | 82.0 (80.0 to 83.9) | 0.76 |
| Gender, n (%) | |||
| Male | 23 (32.9) | 31 (39.7) | |
| Female | 47 (67.1) | 47 (60.3) | 0.38 |
| Residence before admission, n (%) | |||
| Home | 66 (94.3) | 68 (87.2) | 0.11 |
| Nursing Home | 4 (5.7) | 10 12.8) | |
| Cognition, n (%) | |||
| Normal | 67 (95.7) | 74 (94.9) | 0.56 |
| Impaired | 3 (4.3) | 4 (5.1) | |
| No of co-morbidities, mean (95% CI) | 6.3 (5.6 to 6.9) | 6.1 (5.5 to 6.6) | 0.64 |
| Charlson index, mean (95% CI) | 2.3 (1.9 to 2.8) | 2.2 (1.8 to 2.7) | 0.82 |
| Medications at admission, mean (95% CI) | 10.1 (9.0 to 11.2) | 8.8 (7.8 to 9.7) | 0.07 |
| Principal diagnosis at admission, n (%) | |||
| Respiratory | 29 (41.4) | 20 (25.6) | 0.30 |
| Cardiovascular | 8 (11.4) | 14 (18.0) | |
| Falls | 10 (14.3) | 13 (16.7) | |
| CNS | 3 (4.3) | 6 (7.7) | |
| Miscellaneous | 20 (28.6) | 25 (32.1) | |
| BMI, mean (95% CI), kg/m2 | 21.8 (20.7 to 22.8) | 20.6 (19.7 to 21.5) | 0.09 |
| PG-SGA score, mean (95% CI) | 13.3 (12.2 to 14.5) | 12.1 (11.0 to 13.2) | 0.11 |
| EQ-5D-5 L index | 0.6746 (0.617 to 0.729) | 0.6934 (0.638 to 0.746) | 0.62 |
Abbreviations: CI Confidence Interval, CNS Central Nervous System, BMI Body Mass Index PG-SGA, Patient Generated Subjective Global Assessment, EQ-5D-5 L EuroQol 5 Dimensions 5 Levels